検索条件
クリップ | Code No. | 品名 | データ | ||||
---|---|---|---|---|---|---|---|
データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
配列 | 位置 | 温度 | |||||
|
|||||||
TS-M127-1 |
HLA-A*02:01 Mtb Rv1614 Tetramer-FLYELIWNV-PE |
||||||
bacteria | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
FLYELIWNV | 197-205 | 4°C | |||||
TB-M088-2 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLLTVLTV | 12-20 | 4°C | |||||
TB-M088-1 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLLTVLTV | 12-20 | 4°C | |||||
TB-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-M105-2 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQV | 157-165 | 4°C | |||||
TB-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQV | 157-165 | 4°C | |||||
TB-M105-1 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQV | 157-165 | 4°C | |||||
TS-M081-2 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
LLGRNSFEV | 264-272 | 4°C | |||||
TS-M081-1 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
LLGRNSFEV | 264-272 | 4°C | |||||
TB-M107-2 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALDVYNGLL | 299-307 | 4°C | |||||
TB-M107-1 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALDVYNGLL | 299-307 | 4°C | |||||
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SLLPAIVEL | 402-410 | 4°C | |||||
TS-M095-1 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SLLPAIVEL | 402-410 | 4°C | |||||
TS-M117-2 |
HLA-A*02:01 PRAME100-108 Tetramer-VLDGLDVLL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VLDGLDVLL | 100-108 | 4°C | |||||
TS-M117-1 |
HLA-A*02:01 PRAME100-108 Tetramer-VLDGLDVLL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
VLDGLDVLL | 100-108 | 4°C | |||||
TS-M119-2 |
HLA-A*02:01 PRAME142-151 Tetramer-SLYSFPEPEA-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SLYSFPEPEA | 142-151 | 4°C | |||||
TS-M119-1 |
HLA-A*02:01 PRAME142-151 Tetramer-SLYSFPEPEA-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SLYSFPEPEA | 142-151 | 4°C | |||||
TS-M116-2 |
HLA-A*02:01 PRAME300-309 Tetramer-ALYVDSLFFL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALYVDSLFFL | 300-309 | 4°C | |||||
TS-M116-1 |
HLA-A*02:01 PRAME300-309 Tetramer-ALYVDSLFFL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALYVDSLFFL | 300-309 | 4°C | |||||
TS-M118-2 |
HLA-A*02:01 PRAME425-433 Tetramer-SLLQHLIGL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
SLLQHLIGL | 425-433 | 4°C | |||||
TS-M118-1 |
HLA-A*02:01 PRAME425-433 Tetramer-SLLQHLIGL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
SLLQHLIGL | 425-433 | 4°C | |||||
TS-M087-2 |
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KLQCVDLHV | 146-154 | 4°C | |||||
TS-M087-1 |
HLA-A*02:01 PSA Tetramer-KLQCVDLHV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KLQCVDLHV | 146-154 | 4°C | |||||
TB-M120-2 |
HLA-A*02:01 PSA141-150 Tetramer-FLTPKKLQCV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLTPKKLQCV | 141-150 | 4°C | |||||
TS-M104-2 |
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ILSLELMKL | 165-173 | 4°C | |||||
TS-M104-1 |
HLA-A*02:01 RHAMM Tetramer-ILSLELMKL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ILSLELMKL | 165-173 | 4°C | |||||
TS-M096-2 |
HLA-A*02:01 RNA-dependent helicase Tetramer-YLLPAIVHI-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
YLLPAIVHI | 148-156 | 4°C | |||||
TS-M096-1 |
HLA-A*02:01 RNA-dependent helicase Tetramer-YLLPAIVHI-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
YLLPAIVHI | 148-156 | 4°C | |||||
TB-0175-M |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer-KLPDDFTGCV |
||||||
virus | Unlabeled | A*02:01 | 50 µg | ¥190,000 |
0 (お問合せ) |
||
KLPDDFTGCV | -80°C | ||||||
TB-0174-M |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer-RLNEVAKNL |
||||||
virus | A*02:01 | 50 µg | ¥190,000 |
0 (お問合せ) |
|||
RLNEVAKNL | -80°C | ||||||
TB-0177-M |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer-RLQSLQTYV |
||||||
virus | A*02:01 | 50 µg | ¥190,000 |
0 (お問合せ) |
|||
RLQSLQTYV | -80°C | ||||||
TB-0176-M |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer-YLQPRTFLL |
||||||
virus | A*02:01 | 50 µg | ¥190,000 |
0 (お問合せ) |
|||
YLQPRTFLL | -80°C | ||||||
TB-0175-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPDDFTGCV | 4°C | ||||||
TB-0175-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-BV421 |
||||||
virus | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPDDFTGCV | 4°C | ||||||
TB-0175-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPDDFTGCV | 4°C | ||||||
TB-0174-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLNEVAKNL | 4°C | ||||||
TB-0174-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-BV421 |
||||||
virus | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLNEVAKNL | 4°C | ||||||
TB-0174-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLNEVAKNL | 4°C | ||||||
TB-0177-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLQSLQTYV | 4°C | ||||||
TB-0177-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-BV421 |
||||||
virus | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLQSLQTYV | 4°C | ||||||
TB-0177-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLQSLQTYV | 4°C | ||||||
TB-0176-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQPRTFLL | 4°C | ||||||
TB-0176-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-BV421 |
||||||
virus | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQPRTFLL | 4°C | ||||||
TB-0176-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQPRTFLL | 4°C | ||||||
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TS-M085-2 |
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
LMLGEFLKL | 96-104 | 4°C | |||||
TS-M085-1 |
HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
LMLGEFLKL | 96-104 | 4°C | |||||
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-M122-2 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-APC |
||||||
virus VSV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALWALPHAA | 593-601 | 4°C | |||||
TB-M122-1 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-PE |
||||||
virus VSV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALWALPHAA | 593-601 | 4°C | |||||
TS-M140-2 |
HLA-A*02:01 WT137-45 Tetramer-VLDFAPPGA-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
VLDFAPPGA | 37-45 | 4°C | |||||
TS-M140-1 |
HLA-A*02:01 WT137-45 Tetramer-VLDFAPPGA-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
VLDFAPPGA | 37-45 | 4°C | |||||
TS-M100-2 |
HLA-A*03:01 CMV IE1 184-192 Tetramer-KLGGALQAK-APC |
||||||
virus | APC | A*03:01 | 50 tests | ¥209,000 | 1-9 | ||
KLGGALQAK | 184-192 | 4°C | |||||
TS-M100-1 |
HLA-A*03:01 CMV IE1 184-192 Tetramer-KLGGALQAK-PE |
||||||
virus | PE | A*03:01 | 50 tests | ¥209,000 | 1-9 | ||
KLGGALQAK | 184-192 | 4°C | |||||
TS-M124-2 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-APC |
||||||
virus | APC | A*03:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RVRAYTYSK | 148-156 | 4°C | |||||
TS-M124-1 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-PE |
||||||
virus | PE | A*03:01 | 50 tests | ¥209,000 | 1-9 | ||
RVRAYTYSK | 148-156 | 4°C | |||||
TS-M033-2 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-APC |
||||||
virus | APC | A*03:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RLRAEAQVK | 603-611 | 4°C | |||||
TS-M033-1 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-PE |
||||||
virus | PE | A*03:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RLRAEAQVK | 603-611 | 4°C | |||||
TB-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
||||||
cancer | APC | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLAVGATK | 4°C | ||||||
TB-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
||||||
cancer | BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLAVGATK | 4°C | ||||||
TB-0166-1 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
||||||
cancer | PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLAVGATK | 4°C | ||||||
TB-0109-2 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-APC |
||||||
virus HIV |
APC | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLRPGGKKK | 4°C | ||||||
TB-0109-4 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-BV421 |
||||||
virus HIV |
BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLRPGGKKK | 4°C | ||||||
TB-0109-1 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-PE |
||||||
virus HIV |
PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLRPGGKKK | 4°C | ||||||
TB-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
||||||
cancer | APC | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLFGVLRLK | 4°C | ||||||
TB-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
||||||
cancer | BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLFGVLRLK | 4°C | ||||||
TB-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
||||||
cancer | PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLFGVLRLK | 4°C | ||||||
TB-0103-2 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-APC |
||||||
virus Influenza |
APC | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ILRGSVAHK | 4°C | ||||||
TB-0103-4 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-BV421 |
||||||
virus Influenza |
BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ILRGSVAHK | 4°C | ||||||
TB-0103-1 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-PE |
||||||
virus Influenza |
PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ILRGSVAHK | 4°C | ||||||
TB-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
||||||
cancer | APC | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RISTFKNWPK | 4°C | ||||||
TB-0108-4 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-BV421 |
||||||
cancer | BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RISTFKNWPK | 4°C | ||||||
TB-0108-1 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-PE |
||||||
cancer | PE | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RISTFKNWPK | 4°C | ||||||
TS-M135-2 |
HLA-A*11:01 EBV LMP2 S9T Tetramer-SSCSSCPLTK-APC |
||||||
virus | APC | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SSCSSCPLTK | 340-349 | 4°C | |||||
TS-M135-1 |
HLA-A*11:01 EBV LMP2 S9T Tetramer-SSCSSCPLTK-PE |
||||||
virus | PE | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SSCSSCPLTK | 340-349 | 4°C | |||||
TS-M111-2 |
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-APC |
||||||
virus | APC | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SSCSSCPLSK | 340-349 | 4°C | |||||
TS-M111-1 |
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-PE |
||||||
virus | PE | A*11:01 | 50 tests | ¥209,000 | 1-9 | ||
SSCSSCPLSK | 340-349 | 4°C | |||||
TS-M141-2 |
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
DYLQYVLQI | 15-23 | 4°C | |||||
TS-M141-1 |
HLA-A*24:02 ACC-1 Tetramer-DYLQYVLQI-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
DYLQYVLQI | 15-23 | 4°C | |||||
TS-M062-2 |
HLA-A*24:02 Adenovirus 11 Hexon37-45 Tetramer-TYFNLGNKF-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYFNLGNKF | 37-45 | 4°C | |||||
TS-M062-1 |
HLA-A*24:02 Adenovirus 11 Hexon37-45 Tetramer-TYFNLGNKF-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYFNLGNKF | 37-45 | 4°C | |||||
TS-M064-2 |
HLA-A*24:02 Adenovirus 11 Hexon696-704 Tetramer-VYSGSIPYL-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VYSGSIPYL | 696-704 | 4°C | |||||
TS-M064-1 |
HLA-A*24:02 Adenovirus 11 Hexon696-704 Tetramer-VYSGSIPYL-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VYSGSIPYL | 696-704 | 4°C | |||||
TS-M063-2 |
HLA-A*24:02 Adenovirus 5 Hexon37-45 Tetramer-TYFSLNNKF-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYFSLNNKF | 37-45 | 4°C | |||||
TS-M063-1 |
HLA-A*24:02 Adenovirus 5 Hexon37-45 Tetramer-TYFSLNNKF-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYFSLNNKF | 37-45 | 4°C | |||||
TS-M112-2 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
EYRALQLHL | 219-227 | 4°C | |||||
TS-M112-1 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
EYRALQLHL | 219-227 | 4°C | |||||
TB-0117-4 |
HLA-A*24:02 EBV LMP-2 Tetramer-TYGPVFMCL-BV421 |
||||||
virus EBV |
BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TYGPVFMCL | 4°C | ||||||
TS-M035-2 |
HLA-A*24:02 EBV LMP2 C8S Tetramer-TYGPVFMSL-APC |
||||||
virus EBV |
APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYGPVFMSL | 419-427 | 4°C | |||||
TS-M035-1 |
HLA-A*24:02 EBV LMP2 C8S Tetramer-TYGPVFMSL-PE |
||||||
virus EBV |
PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYGPVFMSL | 419-427 | 4°C | |||||
TS-M034-2 |
HLA-A*24:02 EBV LMP2 Tetramer-PYLFWLAAI-APC |
||||||
virus EBV |
APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
PYLFWLAAI | 131-139 | 4°C | |||||
TS-M034-1 |
HLA-A*24:02 EBV LMP2 Tetramer-PYLFWLAAI-PE |
||||||
virus EBV |
PE | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
PYLFWLAAI | 131-139 | 4°C | |||||
TS-M089-2 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VYFFLPDHL | 170-178 | 4°C | |||||
TS-M089-1 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VYFFLPDHL | 170-178 | 4°C | |||||
TS-M044-2 |
HLA-A*24:02 HCV E2 717-725 Tetramer-EYVLLLFLL-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
EYVLLLFLL | 717-725 | 4°C |
※在庫につきましては2024年05月20日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。